Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques

Neurosci Lett. 2002 Jun 28;326(2):117-20. doi: 10.1016/s0304-3940(02)00310-5.

Abstract

The objective of this study was to assess the pathological role of advanced glycation end products (AGE) and the receptor for AGE (RAGE) in Creutzfeldt-Jakob disease (CJD). We immunohistochemically investigated the occipital lobe of three patients with CJD containing with prion protein (PrP) plaques using anti-AGE and RAGE antibodies. Many PrP-positive plaques were observed in these patients, and the PrP-positive prion plaques also showed immunoreactivity for the anti-AGE antibody. Furthermore, many astrocytes contained-PrP positive granules, and the same astrocytes also contained many AGE- and RAGE-immunopositive granules. The staining pattern of these granules showed good concordance with that of PrP. These findings suggest that there may be a RAGE-mediated PrP degradation pathway in CJD as is the case for beta-amyloid protein in Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / metabolism
  • Brain / metabolism*
  • Brain / pathology*
  • Creutzfeldt-Jakob Syndrome / metabolism*
  • Creutzfeldt-Jakob Syndrome / pathology*
  • Cytoplasmic Granules / metabolism
  • Glycation End Products, Advanced / metabolism*
  • Humans
  • Immunohistochemistry / methods
  • Occipital Lobe / metabolism
  • Occipital Lobe / pathology
  • Prions / metabolism*
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / metabolism*
  • Staining and Labeling

Substances

  • Glycation End Products, Advanced
  • Prions
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic